Supporting young hematology researchers: training programs offered by EHA and ASH
This interview provides an exciting insight into the Translational Research Training in Hematology (TRTH) and the Clinical Research Training in Hematology ...
VJHemOnc – Video Journal of Hematological Oncology
Update on hematology work in Oxford
Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD, of the Oxford University Hospitals NHS Foundation Trust, Oxford, UK, gives us an update on hematology work ...
VJHemOnc – Video Journal of Hematological Oncology
Prevention & treatment of major infectious diseases in hematology/oncology patients in the COVID era
IACH Webinar Series September 22, 2020.
International Academy for Clinical Hematology IACH
GUEST LECTURES MULTIPLE MYELOMA
Welcome address & Introduction of speaker Dr M B Agarwal, Mumbai Guest Speaker: Dr Shaji Kumar, USA 1. Lecture: Treatment of newly diagnosed multiple ...
Manage Health Foundation MHF
Hemophilia-A
Manage Health Foundation MHF
The potential of differentiation therapies for AML
Stéphane de Botton, MD, PhD of the Gustave Roussy Institute, Villejuif, France, discusses the efficiency of differentiation therapies for the elimination of acute ...
VJHemOnc – Video Journal of Hematological Oncology
Hematology and Oncology Update for Pediatricians | 16 September 2020 | Emcure | HCMPL
Horizon Conference Management organized a webinar "Hematology and Oncology Update for Pediatricians" with support of the "Emcure Pharmaceuticals".
Horizon Conference Management
The role of nurses in CAR T-cell therapy
Erik Aerts, RN, Haematology Nurses & Healthcare Professionals Group, University Hospital Zurich, Zurich, Switzerland, discusses the key topics from the nurses' ...
VJHemOnc – Video Journal of Hematological Oncology
Chronic Myeloid Leukemia: FUTURISTIC VIEWS
Manage Health Foundation MHF
HM-PRO: collecting specific QoL and symptom data for hematological malignancies
Quality of life and symptom data are essential for informing treatment plans as a clinician, as Esther Oliva, MD, Chair of the European Haematology Association ...
VJHemOnc – Video Journal of Hematological Oncology
tutorial: 19th Hematology tutorial
6.05.2011 Tallinn.
MIND Media
The value of collaborative research in Hematology: Balkan Myeloma Study Group
HeaDS 24th EHA Satellite Symposium Prof. Meral Beksac Professor of Hematology, University of Ankara.
Health Data Specialists
EHA 2019 program: insights from the Chair of the Scientific Program Committee
Maria-Victoria Mateos, Chair of the Scientific Program Committee of the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam ...
VJHemOnc – Video Journal of Hematological Oncology
Ε. Φουκαράκης | Περιστατικό
26/9Αίθουσα Mc2 - 10:00-11:50 Αρρυθμιολογικά Περιστατικά σε ασθενείς με Μυοκαρδιοπάθειες ΙI Πρόεδροι: Ι. Κανακάκης,Ε. Πράππα,Β. Βασιλικός 10:00-10:05 ...
Livemedia
Bernardo Rapoport on touchONCOLOGY.com
Editorial Board member Bernardo Rapoport talks about his favourite features of European Oncology & Haematology and touchONCOLOGY.com.
Touch Medical Media Services
EHA 2017: keeping in touch with the world
Robin Foà, MD from Sapienza University of Rome, Rome, Italy provides an overview on how the European Haematology Association (EHA) has expanded at ...
VJHemOnc – Video Journal of Hematological Oncology
Improved survival in MM with thalidomide before and after ASCT
The 23rd congress of the European Haematology Association (EHA) 2018, held in Stockholm, Sweden, presented exciting data for multiple myeloma (MM).
VJHemOnc – Video Journal of Hematological Oncology
The regulation of personalized medicine trials
Ulrich Jäger, MD , Medical University of Vienna, Vienna, Austria, discusses his view, from the clinical perspective, on the regulation of personalized medicine ...
VJHemOnc – Video Journal of Hematological Oncology
Immunotherapeutics against multiple myeloma: it's all about BCMA
Enrique Ocio, MD, PhD, from the University Hospital of Salamanca, Salamanca, Spain, gives an account of current immunotherapies for multiple myeloma (MM) ...
VJHemOnc – Video Journal of Hematological Oncology
The evolving imaging of multiple myeloma
Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Evangelos Terpos, ...
VJHemOnc – Video Journal of Hematological Oncology
Updated POLLUX results for early relapsed myeloma patients
Saad Usmani, MD, of the University of North Carolina School of Medicine, Chapel Hill, NC, updates us at the European School of Haematology (ESH) ...
VJHemOnc – Video Journal of Hematological Oncology
Targeting BCMA with bispecific antibodies in R/R myeloma
Saad Usmani, MD, of the University of North Carolina School of Medicine, Chapel Hill, NC, presents exciting results from clinical trials for bispecific antibodies ...
VJHemOnc – Video Journal of Hematological Oncology
What is the role of PET/CT in myeloma management?
Functional imaging techniques serve an essential role in diagnostics. Here, Elena Zamagni, MD, PhD, of the University of Bologna, Bologna, Italy, highlights the ...
VJHemOnc – Video Journal of Hematological Oncology
EHA 2017 - Interview - Dr David Gómez Almaguer
An interview with Dr David Gómez Almaguer (Hospital Universitario Dr José Eleuterio Gonzalez, Mexico) at this year's EHA congress held in Madrid, Spain.
EMG-Health
iNNOVATE results: a prospective new standard of care for Waldenström’s
The purpose of the iNNOVATE study (NCT02165397) was to evaluate the safety and efficacy of ibrutinib and rituximab for the treatment of Waldenström's ...
VJHemOnc – Video Journal of Hematological Oncology
Key EHA data, and what to watch for at ASH
Ulrich Jäger, MD , Medical University of Vienna, Vienna, Austria, discusses the key data from EHA, and what he will be following in the lead-up to ASH at the ...
VJHemOnc – Video Journal of Hematological Oncology
Publication in Practice: Immune Thrombocytopenia Purpura
Knowledge is evolving regarding numerous clinical aspects of immune thrombocytopenia purpura (ITP), and there remains significant variability in clinical ...
ImedexCME
The rapid progression of IDH1/2 mutant enzyme inhibitors through clinical trials
In this video, Stéphane de Botton, MD, PhD of the Gustave Roussy Institute, Villejuif, France, describes the rapid progression of IDH1/2 mutant inhibitors through ...
VJHemOnc – Video Journal of Hematological Oncology
The clot thickens
Press brief by Katherine A High, MD of the The Children's Hospital of Philadelphia, at the 2016 Annual Meeting of the European Association of Hematology ...
VJHemOnc – Video Journal of Hematological Oncology
Primary CNS lymphoma: can we use MATRix immunochemo in the real world?
MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG32 trial (NCT01011920) for primary CNS lymphoma ...
VJHemOnc – Video Journal of Hematological Oncology
What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson
Paul G. Richardson, MD discusses how novel and next-generation therapy helps in the management of newly-diagnosed multiple myeloma patients, as well as ...
Dana-Farber Cancer Institute
Where will we be in MM management 5 years from now?
Elena Zamagni, MD, PhD, of the University of Bologna, Bologna, Italy, discusses the future landscape of multiple myeloma (MM) management at the European ...
VJHemOnc – Video Journal of Hematological Oncology
Next-generation methodologies: the future for MRD monitoring in ALL?
Measurable residual disease (MRD) is a significant prognostic factor in acute lymphoblastic leukemia (ALL), and as such it is important to establish standardized ...
VJHemOnc – Video Journal of Hematological Oncology
Working with smaller research companies
Speaking from the International Conference on Acute Myeloid Leukaemia 2017, Estoril, Portugal by the European School of Haematology (ESH), Stéphane de ...
VJHemOnc – Video Journal of Hematological Oncology
iwCLL: what to expect
Peter Hillmen, MBChB, FRCP, FRCPath, PhD, of the University of Leeds, Leeds, UK, give us an overview of what to expect this September at this year's iwCLL ...
VJHemOnc – Video Journal of Hematological Oncology
Clinical data for CD19-directed CAR T-cell products in ALL
Claire Roddie, MD, PhD, from University College London Hospitals NHS Foundation Trust, London, UK, explains how CD19-directed CAR T-cells is probably ...
VJHemOnc – Video Journal of Hematological Oncology
A new set of treatment options for low-risk MDS
Treatments for low-risk myelodysplastic syndromes (MDS) cannot cure the disease, but rather aim to improve quality of life, reduce complications and increase ...
VJHemOnc – Video Journal of Hematological Oncology
Novel agent combinations: the future of CLL
There has been an influx of novel agents in the field of chronic lymphocytic leukemia (CLL) in recent years. These include venetoclax, ibrutinib and ...
VJHemOnc – Video Journal of Hematological Oncology
Developing a patient-reported outcome instrument for Gaucher disease
There are several genetic instruments available to measure the impact of Gaucher Disease (GD) on a patient's quality of life, but no specific measure by which ...
VJHemOnc – Video Journal of Hematological Oncology
Manufacturing of CAR T-cells: new approaches
Claire Roddie, MD, PhD, of University College London (UCL) Hospitals NHS Foundation Trust, London, UK, explains how UCL have collaborated with Multani ...
VJHemOnc – Video Journal of Hematological Oncology
Advances in the treatment and prognosis of TTP
Paul Coppo, MD, Saint-Antoine University Hospital, Paris, France, discusses advances in the treatment and prognosis of thrombotic thrombocytopenic purpura ...
VJHemOnc – Video Journal of Hematological Oncology
Future treatment combinations for myeloma
Multiple myeloma (MM) therapy has evolved rapidly in recent years, and is showing no sign of slowing. Here, Kenneth Anderson, MD, from Harvard Medical ...
VJHemOnc – Video Journal of Hematological Oncology
